Vanguard Capital Management
REPL icon

Vanguard Capital Management’s Replimune Group REPL Stock Holding History

Vanguard Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1M Buy
2,896,004
+136,884
+5% +$837K ﹤0.01% 2170
2026
Q1 		$21.1M Buy
+2,759,120
New +$21.1M ﹤0.01% 2311

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management's REPL Position: Q2 2026 in Review

Vanguard Capital Management increased its Replimune Group (REPL) stake by 5% in Q2 2026, buying an estimated $837K and bringing the position to 2,896,004 shares worth $32.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Vanguard Capital Management first reported a position in REPL in Q1 2026 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Vanguard Capital Management held 2,896,004 shares of Replimune Group worth $32.1M as of Q2 2026.
  • Vanguard Capital Management bought 136,884 Replimune Group shares in Q2 2026, an estimated $837K.
  • Replimune Group made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2170 holding.
  • Vanguard Capital Management first reported a position in Replimune Group in Q1 2026 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.